Health Advancements in Indolent Systemic Mastocytosis Treatments Show Promise The treatment landscape for indolent systemic mastocytosis (ISM) is evolving, with new therapies and research shedding light on potential improvements in patient outcomes. Clinical... Editorial12 hours ago